Novo Nordisk launches a $56.50 per share bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and highlighting the strategic value of Metsera's GLP-1 pipeline.
Trump urges Senate Republicans to end government shutdown by eliminating the filibuster, despite GOP leaders' caution and the mounting economic toll on federal workers and programs.
Novo Nordisk launches a $56.50 per share bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and highlighting the strategic value of Metsera's GLP-1 pipeline.
Trump urges Senate Republicans to end government shutdown by eliminating the filibuster, despite GOP leaders' caution and the mounting economic toll on federal workers and programs.